Detalhe da pesquisa
1.
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
J Clin Oncol
; 14(1): 268-76, 1996 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8558208
2.
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
J Clin Endocrinol Metab
; 84(10): 3545-50, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10522993
3.
Standardization of two immunological HbA1c routine assays according to the new IFCC reference method.
Clin Lab
; 49(11-12): 657-61, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14651337
4.
[Osteoporosis in multiple myeloma]. / Problém osteoporózy pri mnohopocetnom myelóme.
Vnitr Lek
; 44(11): 649-53, 1998 Nov.
Artigo
em Sk
| MEDLINE | ID: mdl-10422504
5.
The influence of renal function on NT-proBNP levels in various disease groups.
Clin Lab
; 49(11-12): 649-56, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14651336
6.
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
Br J Cancer
; 75(2): 295-300, 1997.
Artigo
em Inglês
| MEDLINE | ID: mdl-9010041